Loading clinical trials...
Loading clinical trials...
A Phase 2 Double Blind, Randomized, Placebo Controlled Trial inVEstigating the Effect and Safety of Several Dosing Regimens of LY3056480 in Patients With STAble Sensorineural Hearing Loss
Conditions
Interventions
LY3056480
Locations
3
United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
New York Eye and Ear Infirmary ICAHN school of Medicine Mount Sinai
New York, New York, United States
Eastern Virginia Medical School
Norfolk, Virginia, United States
Start Date
September 1, 2022
Primary Completion Date
September 1, 2024
Completion Date
March 1, 2025
Last Updated
August 25, 2022
NCT04591093
NCT06229717
NCT07039435
NCT05402813
NCT06495268
NCT07452653
Lead Sponsor
Audion Therapeutics BV
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions